A narrative review evaluates preclinical evidence for pairing the anesthetic dexmedetomidine with biomaterial scaffolds to ...
A retrospective single-center study found that adding low-dose dexmedetomidine to ciprofol was associated with fewer ...
Teva's celiac disease drug TEV-408 became the first treatment to protect celiac patients' intestines from gluten damage in a ...
Teva Pharmaceutical's inaugural R&D Day unveiled three first-in-class drugs targeting Tourette syndrome in children, celiac disease, and IBD -- conditions no approved therapy fully addresses -- ...
Series: "Delirium and Sleep Rhythms" #12Key Points of This IssueIn the previous meta-analysis, it was dexmedetomidine that ...
ASAM has issued its first national clinical considerations on recognizing and treating medetomidine use and withdrawal in the ...
BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults ...
Series: "Delirium and Sleep Rhythms" #11Key Points of This IssueChapter 3 discusses preventive interventions. Does regulating ...
Medetomidine is complicating withdrawal from illicit drugs, leaving people struggling to find treatment that can help them ...